|Siegfried AG sells 100% of Siegfried Biologics (Germany) to Avestha Biotherapeutics and Research in India.|
|Target Company Name||Siegfried Biologics GmbH|
|Buyer Name / MBO Team / MBI Team||Avestha Biotherapeutics and Research Pvt. Ltd.|
Siegfried AG (Zofingen, Switzerland), a publicly quoted chemical / pharmaceutical company (SWX: SFZN) sells 100% of Siegfried Biologics GmbH (Berlin, Germany), to Avestha Biotherapeutics and Research Pvt. Ltd. (Bangalore, India), a leading Indian biotech development company.
Vaccani, Zweig & Associates acted as exclusive M&A advisors to Siegfried AG in all phases of the sales process.
|ICFG Office||Zurich: A. Vaccani & Partners, Switzerland|
|ICFG Advisory||ICFG Zurich acted as exclusive advisor to the selller in 2007.|